Nanobiotix (NBTX) — Cash Flow-to-Debt Ratio
Nanobiotix (NBTX) has a Cash Flow-to-Debt Ratio of -0.11x as of December 2025, meaning its operating cash flow of $-16.01 Million could theoretically repay 0% of its total liabilities ($152.24 Million) in one year. See NBTX FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Nanobiotix Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Nanobiotix across 15 annual periods. Also explore NBTX year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Nanobiotix (2011–2025)
Year-by-year debt coverage analysis for Nanobiotix. For market capitalisation and broader financial context, see Nanobiotix (NBTX) total market value.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.22x | $-33.42 Million | $152.24 Million | ▼ -49.5% |
| 2024 | -0.15x | $-19.55 Million | $133.12 Million | ▼ -12.7% |
| 2023 | -0.13x | $-12.48 Million | $95.74 Million | ▲ +69.5% |
| 2022 | -0.43x | $-37.10 Million | $86.81 Million | ▼ -7.3% |
| 2021 | -0.40x | $-29.87 Million | $74.98 Million | ▲ +8.0% |
| 2020 | -0.43x | $-27.54 Million | $63.56 Million | ▲ +38.8% |
| 2019 | -0.71x | $-41.17 Million | $58.11 Million | ▲ +12.9% |
| 2018 | -0.81x | $-25.98 Million | $31.95 Million | ▲ +47.4% |
| 2017 | -1.55x | $-20.95 Million | $13.54 Million | ▼ -10.0% |
| 2016 | -1.41x | $-18.28 Million | $13.00 Million | ▲ +9.7% |
| 2015 | -1.56x | $-16.82 Million | $10.81 Million | ▼ -22.5% |
| 2014 | -1.27x | $-8.56 Million | $6.74 Million | ▲ +20.8% |
| 2013 | -1.60x | $-6.83 Million | $4.26 Million | ▼ -42.2% |
| 2012 | -1.13x | $-3.76 Million | $3.33 Million | ▲ +54.0% |
| 2011 | -2.45x | $-4.87 Million | $1.99 Million | — |